From: HMOX1 STR polymorphism and malaria: an analysis of a large clinical dataset
Country | Total number | Cases (% total) | SMA (% cases) | CM (% cases) | Both (% cases) |
---|---|---|---|---|---|
Burkina Faso | 1327 | 733 (55.2%) | 28 (3.8%) | 94 (12.8%) | 18 (2.5%) |
Cameroon | 1277 | 592 (46.4%) | 66 (11.1%) | 32 (5.4%) | 8 (1.4%) |
Gambia | 5091 | 2487 (48.9%) | 456 (18.3%) | 780 (31.4%) | 134 (5.4%) |
Ghana | 716 | 396 (55.3%) | 41 (10.4%) | 31 (7.8%) | 5 (1.3%) |
Kenya | 3261 | 1646 (50.5%) | 174 (10.6%) | 690 (41.9%) | 189 (11.5%) |
Malawi | 2499 | 1182 (47.3%) | 65 (5.5%) | 642 (54.3%) | 109 (9.2%) |
Mali | 446 | 263 (59%) | 81 (30.8%) | 61 (23.2%) | 51 (19.4%) |
Nigeria | 131 | 109 (83.2%) | 1 (0.9%) | 28 (25.7%) | 0 (0%) |
PNG | 770 | 396 (51.4%) | 115 (29%) | 49 (12.4%) | 7 (1.8%) |
Tanzania | 807 | 409 (50.7%) | 178 (43.5%) | 31 (7.6%) | 25 (6.1%) |
Vietnam | 1264 | 718 (56.8%) | 23 (3.2%) | 154 (21.4%) | 4 (0.6%) |